Genentech and City of Hope Sues Glaxo Group, Human Genome Sciences and Lonza Biologics

  • April 14, 2011

Genentech and City of Hope files suit against Glaxo Group, Human Genome Sciences, and Lonza Biologics over a patent related to methods of making antibody heavy and light chains having specificity for a desired antigen. 4/12, Central District of California, 2:2011cv03065.


Access to the full article is currently available to RPX members only. Please contact us if you need further information.



×
×

Thank you for your feedback

×
×